Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Latest News

FDA Grants Fast Track Designation to Batiraxcept for Advanced or Metastatic Clear Cell RCC
FDA Grants Fast Track Designation to Batiraxcept for Advanced or Metastatic Clear Cell RCC

November 30th 2022

The FDA has granted a fast track designation to batiraxcept for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma who have progressed after 1 or 2 prior lines of systemic therapy that include both immuno-oncology–based and VEGF TKI–based therapies, either in combination or sequentially.

PROSPER-RCC Results May Inform Further Research on Neoadjuvant IO Approaches in RCC
PROSPER-RCC Results May Inform Further Research on Neoadjuvant IO Approaches in RCC

November 29th 2022

ARRY-614 Plus Immune Checkpoint Inhibition Can Induce Durable Responses in Advanced Solid Tumors
ARRY-614 Plus Immune Checkpoint Inhibition Can Induce Durable Responses in Advanced Solid Tumors

November 28th 2022

ADCs Represent One of Many Improvements in GU Cancer Treatment
ADCs Represent One of Many Improvements in GU Cancer Treatment

November 28th 2022

Rapid Developments Generate Waves  of Excitement for Patients With RCC
Rapid Developments Generate Waves of Excitement for Patients With RCC

November 17th 2022

Video Series
Video Interviews
Podcasts

More News